Form 4: Opaleye Management Boosts Alpha Cognition Stake

Opaleye Management Inc., a 10% owner of Alpha Cognition Inc., reported an acquisition of 1,331 common shares at a weighted average price of $5.782.

Summary

• Opaleye Management Inc. acquired 1,331 shares of Alpha Cognition Inc. common stock on March 16, 2026.
• The shares were purchased at a weighted average price of $5.782, with individual transaction prices ranging from $5.76 to $5.79.
• Following this transaction, Opaleye Management Inc. indirectly beneficially owns a total of 2,525,343 shares of Alpha Cognition Inc.
• These shares are held through Opaleye, L.P. (2,435,343 shares) and a separately managed account (90,000 shares).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a major institutional investor and 10% owner is increasing its stake, suggesting continued belief in the company's value.

Positives

• A significant shareholder, Opaleye Management Inc., increased its stake in Alpha Cognition Inc., indicating continued confidence in the company's future prospects.
• The purchase price of $5.782 provides a specific valuation point at which a major institutional investor found the shares attractive.

Negatives

• The number of shares acquired (1,331) is relatively small compared to Opaleye Management Inc.'s total beneficial ownership, suggesting a minor incremental increase rather than a substantial new investment.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it primarily reports a completed transaction.

Industry Context

StockSavvy.ai notes that insider purchases, even small ones, can signal confidence from large institutional investors like Opaleye Management Inc. in the company's future prospects, especially in the biotechnology or pharmaceutical sector where Alpha Cognition Inc. likely operates, given its name.

Comparison to Industry Standards

• This Form 4 filing reports a standard insider transaction. StockSavvy.ai observes that such filings are routine for 10% owners increasing their stake.
• Without specific industry benchmarks for similar-sized purchases by institutional investors in the biotech sector, a direct comparison of the transaction's magnitude is not readily available.
• The price range of $5.76 to $5.79 provides a specific data point for ACOG's valuation at the time of purchase.

Related Party Transactions

• Opaleye Management Inc., a 10% owner of Alpha Cognition Inc., purchased common stock from the open market, which is a related party transaction by definition under SEC rules for insider reporting.

Stakeholder Impact

• Shareholders: May view the purchase as a positive sign of confidence from a major investor, potentially bolstering sentiment.
• Management: Could be encouraged by continued institutional support and validation of the company's strategy.

Key Dates

Recommendation

The purchase by a 10% owner is a positive indicator of confidence, but the relatively small volume of shares acquired does not suggest a strong catalyst for immediate significant price movement. It reinforces a 'hold' position for existing investors and suggests that the stock remains on the radar for institutional interest.

Keywords

Alpha Cognition Inc., ACOG, Opaleye Management Inc., Insider Trading, Form 4, Beneficial Ownership, Stock Purchase, Investment Management, Equity Acquisition